A recent retrospective study demonstrated that ERBB2 overexpression was associated with significantly shorter disease-free survival in patients with CCA who underwent curative resection than in those who did not, and it has been identified as an independent prognostic factor for recurrence after treatment [120]. Here, ERBB2 is linked to cholangiocarcinoma.